SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • August 22nd, 2017 • Cti Biopharma Corp • Pharmaceutical preparations • Washington
Contract Type FiledAugust 22nd, 2017 Company Industry JurisdictionThis Separation and Release Agreement (this “Agreement”) is entered by and between Matthew Plunkett (“Executive”) and CTI BioPharma Corp., a Washington corporation (the “Company”), on this 22nd day of August, 2017 (the “Effective Date”).